Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does NIVOLUMAB\RELATLIMAB Cause Off label use? 6 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Off label use have been filed in association with NIVOLUMAB\RELATLIMAB. This represents 11.1% of all adverse event reports for NIVOLUMAB\RELATLIMAB.

6
Reports of Off label use with NIVOLUMAB\RELATLIMAB
11.1%
of all NIVOLUMAB\RELATLIMAB reports
0
Deaths
0
Hospitalizations

How Dangerous Is Off label use From NIVOLUMAB\RELATLIMAB?

Of the 6 reports.

Is Off label use Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for NIVOLUMAB\RELATLIMAB. However, 6 reports have been filed with the FAERS database.

What Other Side Effects Does NIVOLUMAB\RELATLIMAB Cause?

Secondary adrenocortical insufficiency (10)

What Other Drugs Cause Off label use?

RITUXIMAB (39,751) INFLIXIMAB (34,801) DENOSUMAB (34,612) METHOTREXATE (24,020) VEDOLIZUMAB (21,017) ETANERCEPT (20,178) TOCILIZUMAB (18,256) PREDNISONE (17,867) LENALIDOMIDE (17,017) ADALIMUMAB (16,417)

Related Pages

NIVOLUMAB\RELATLIMAB Full Profile All Off label use Reports All Drugs Causing Off label use NIVOLUMAB\RELATLIMAB Demographics